Home › Funds › Blue Owl Capital Holdings LP › IMMX
Blue Owl Capital Holdings LP position in IMMX
IMMIX BIOPHARMA INC · Health Care
Blue Owl Capital Holdings LP reported holding 602,047 shares of IMMX (IMMIX BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 1.18% of its reported portfolio and ranking #15 among its reported holdings. Blue Owl Capital Holdings LP has disclosed IMMX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's IMMX position evolved
Blue Owl Capital Holdings LP first disclosed a stake in IMMX in Q4 2025 at 986,240 shares (US$5.2M). The position peaked in Q3 2026 at 602,047 shares, worth US$6.3M. Across 4 filings, Blue Owl Capital Holdings LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 602,047 shares valued at US$6.3M — an increase of 164,495 shares quarter over quarter.. Notable position changes include a 44% trim in Q1 2026 (shares rose 13% over the following quarter), a 38% increase in Q3 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 986.24K | $5.16M | New |
| Q1 2026 | 547.55K | $4.99M | Reduce |
| Q2 2026 | 437.55K | $4.51M | Reduce |
| Q3 2026 | 602.05K | $6.26M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC) is a Health Care company. 95 other funds we track also report a position in IMMX — the largest reported positions include Saturn V Capital Management LP (US$48.0M), Deep Track Capital, LP (US$28.6M), Opaleye Management Inc. (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- Saturn V Capital Management LP 4.66M sh · $48.03M · Q2 2026
- Deep Track Capital, LP 2.77M sh · $28.61M · Q2 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- GREAT POINT PARTNERS LLC 1.28M sh · $13.17M · Q2 2026
- Velan Capital Investment Management LP 1.08M sh · $11.19M · Q2 2026
- Bleichroeder LP 1.00M sh · $10.40M · Q3 2026
- Logos Global Management LP 1.00M sh · $10.31M · Q2 2026
- Monashee Investment Management LLC 450.00K sh · $4.68M · Q3 2026
- KVP Capital Advisors, LP 230.42K sh · $2.38M · Q2 2026
- Imprint Wealth LLC 26.23K sh · $270.46K · Q2 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held IMMX?
Blue Owl Capital Holdings LP has disclosed IMMX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Blue Owl Capital Holdings LP's current position in IMMX?
As of Q3 2026, Blue Owl Capital Holdings LP holds 602.05K shares of IMMX (IMMIX BIOPHARMA INC), valued at $6.26M, representing 1.18% of its reported portfolio and ranking #15.
Has Blue Owl Capital Holdings LP been buying or selling IMMX?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP increased its position in IMMX. The position peaked in Q3 2026 at 602.05K shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include Saturn V Capital Management LP, Deep Track Capital, LP, Opaleye Management Inc., among 95 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.